In 2024, UnitedHealth CEO Andrew Witty earned $26.3 million, leading health insurance payer executive compensation amid manageable Medicare Advantage costs and leadership changes in major firms.

Study reveals shifting patterns in home health care use among Medicare Advantage enrollees, highlighting implications for care quality, equity, and policy in U.S. Medicare programs.

2024 health insurer CEO pay ratios reveal top executives earning up to 370 times median staff. Medicare Advantage costs remain elevated but manageable as per insurers' financial disclosures.

Explore critical U.S. public health and policy updates affecting healthcare insurance, including COVID-19 booster guidance, AI diagnostics, Medicare Advantage reforms, and expanding HIV challenges in Texas.

Explore how the Advisory Board supports healthcare leaders with insights and strategies on industry trends, FDA approvals, AI, and health equity shaping the U.S. insurance and healthcare sectors.

Social Security in Houston faces increasing delays due to staffing cuts and higher call volumes, impacting benefit approvals and service access. Learn how these challenges affect Texas beneficiaries and federal service modernization efforts.

HaysMed CEO Edward Herrman joined a key HHS healthcare policy roundtable discussing rural healthcare challenges, Medicare Advantage concerns, regulatory burdens, and AI opportunities. Insights to inform federal support and reform.

U.S. Rep. Richard Neal discusses the potential impact of federal budget cuts to Medicaid and Medicare on Massachusetts long-term care providers and residents.

Explore how Medicare Part D and C plans cover Jardiance for heart failure and type 2 diabetes, including costs, formularies, and pricing reforms under the Inflation Reduction Act.

Medicare beneficiaries face higher costs as Part D plans shift from fixed co-pays to coinsurance for expensive Tier 3 drugs, raising out-of-pocket expenses significantly.